These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8651004)
1. Hormone replacement therapy and vaginal bleeds. Theoretical aspects and clinical management. Samsioe G Zentralbl Gynakol; 1996; 118(4):181-7. PubMed ID: 8651004 [No Abstract] [Full Text] [Related]
2. [Climacteric--from the viewpoint of the established gynecologist. Interview by Jeanette Gerhardt]. Gericke DS Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):IX-X. PubMed ID: 8150240 [No Abstract] [Full Text] [Related]
3. [Hormone substitution in climacteric. Position of the German Menopause Society]. Schneider HP; Kuhl H; Dören M; Hesch D Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352 [No Abstract] [Full Text] [Related]
4. Estrogens and progestins: what to use and how to use it. Jones KP Clin Obstet Gynecol; 1992 Dec; 35(4):871-83. PubMed ID: 1451370 [No Abstract] [Full Text] [Related]
5. [-Psychosocial aspects of hormone substitution in postmenopause-]. Buddeberg C Arch Gynecol Obstet; 1995; 256 Suppl():S198-203. PubMed ID: 8619658 [No Abstract] [Full Text] [Related]
6. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H; Taubert HD Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
7. [Hepatic changes in different hormone replacement therapies in climacteric]. Foth D; Römer T; Panzig E Zentralbl Gynakol; 1995; 117(7):349-52. PubMed ID: 7668064 [TBL] [Abstract][Full Text] [Related]
8. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause]. Wuttke W Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280 [No Abstract] [Full Text] [Related]
9. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
10. [Long-term hormone replacement and risk of breast carcinoma: current status. On behalf of the German Menopause Society and the Professional Society of Gynecologic Endocrinology and Reproductive Medicine of the German Society of Gynecology and Obstetrics]. Kuhl H; Runnebaum B; Schneider HP Zentralbl Gynakol; 1995; 117(10):549-53. PubMed ID: 7491838 [No Abstract] [Full Text] [Related]
14. [Diagnosis and evaluation of climacteric symptoms. The "Menopause Rating Scale" MRS helps in diagnosis and evaluation of therapeutic effectiveness]. Hauser GA Fortschr Med; 1996 Feb; 114(5):49-52. PubMed ID: 8867476 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)]. Hauser GA; Ernst U Zentralbl Gynakol; 1999; 121(11):530-6. PubMed ID: 10612221 [No Abstract] [Full Text] [Related]